{"id":"https://openalex.org/W3090176981","doi":"https://doi.org/10.1080/17446651.2020.1830759","title":"Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes","display_name":"Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes","alternate_titles":[],"publication_year":2020,"publication_date":"2020-09-29","ids":{"openalex":"https://openalex.org/W3090176981","doi":"https://doi.org/10.1080/17446651.2020.1830759","mag":"3090176981","pmid":"https://pubmed.ncbi.nlm.nih.gov/33030356"},"language":"en","primary_location":{"id":"doi:10.1080/17446651.2020.1830759","doi":"https://doi.org/10.1080/17446651.2020.1830759","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17446651.2020.1830759","pdf_url":null,"source":{"id":"https://openalex.org/S185495692","display_name":"Expert Review of Endocrinology & Metabolism","issn_l":"1744-6651","issn":["1744-6651","1744-8417"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3090176981"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086072427","display_name":"Juan P. Fr\u00edas","orcid":"https://orcid.org/0000-0001-9486-1255","observed_orcids":["https://orcid.org/0000-0001-9486-1255"]},"institutions":[{"id":"https://openalex.org/I4210111119","display_name":"National Research Institute","ror":"https://ror.org/02201aj62","country_code":"US","type":"other","lineage":["https://openalex.org/I4210111119"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Juan P Fr\u00edas","raw_affiliation_strings":["Clinical Research, National Research Institute, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, National Research Institute, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I4210111119"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5086072427"],"corresponding_institution_ids":["https://openalex.org/I4210111119"],"apc_list":null,"apc_paid":null,"fwci":1.1495,"has_fulltext":false,"cited_by_count":82,"citation_normalized_percentile":{"value":0.78356412,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"15","issue":"6","first_page":"379","last_page":"394"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8009999990463257},{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.8560000061988831},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8629999756813049},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.9229999780654907},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.8320000171661377},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8479999899864197},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7789999842643738},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8500000238418579},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.7350000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7961015105247498},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7194775342941284},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.677445650100708},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5802793502807617},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4719276428222656},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.46549996733665466},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43926432728767395},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4225255846977234},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.4192761480808258},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.4174298644065857},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.31039729714393616},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.17310741543769836}],"mesh":[{"descriptor_ui":"D000097789","descriptor_name":"Glucagon-Like Peptide-1 Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000098860","descriptor_name":"Tirzepatide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/17446651.2020.1830759","doi":"https://doi.org/10.1080/17446651.2020.1830759","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17446651.2020.1830759","pdf_url":null,"source":{"id":"https://openalex.org/S185495692","display_name":"Expert Review of Endocrinology & Metabolism","issn_l":"1744-6651","issn":["1744-6651","1744-8417"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Review of Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:33030356","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33030356","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert review of endocrinology & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W1967295307","https://openalex.org/W1967442749","https://openalex.org/W1969932276","https://openalex.org/W2054564814","https://openalex.org/W2067710447","https://openalex.org/W2096344196","https://openalex.org/W2109728760","https://openalex.org/W2111549935","https://openalex.org/W2127307547","https://openalex.org/W2150959326","https://openalex.org/W2159205789","https://openalex.org/W2164249826","https://openalex.org/W2193379135","https://openalex.org/W2199333711","https://openalex.org/W2317095451","https://openalex.org/W2460039851","https://openalex.org/W2519803668","https://openalex.org/W2607109151","https://openalex.org/W2787255324","https://openalex.org/W2788154323","https://openalex.org/W2797296317","https://openalex.org/W2806521060","https://openalex.org/W2808030638","https://openalex.org/W2894993577","https://openalex.org/W2895135221","https://openalex.org/W2895533920","https://openalex.org/W2895666357","https://openalex.org/W2902410297","https://openalex.org/W2908397509","https://openalex.org/W2918407168","https://openalex.org/W2936477874","https://openalex.org/W2948086981","https://openalex.org/W2961575013","https://openalex.org/W2968073288","https://openalex.org/W2969584990","https://openalex.org/W2969925328","https://openalex.org/W2972438698","https://openalex.org/W2978840913","https://openalex.org/W2983665884","https://openalex.org/W2984893157","https://openalex.org/W2989619493","https://openalex.org/W2990930253","https://openalex.org/W2995278588","https://openalex.org/W3000683010","https://openalex.org/W3004172664","https://openalex.org/W3004190317","https://openalex.org/W3004838676","https://openalex.org/W3008859491","https://openalex.org/W3011482816","https://openalex.org/W3012179734","https://openalex.org/W3015345942","https://openalex.org/W3021170016","https://openalex.org/W3030023482","https://openalex.org/W3034659525","https://openalex.org/W3034728361","https://openalex.org/W3035308344","https://openalex.org/W3167376541"],"related_works":["https://openalex.org/W4306155811","https://openalex.org/W4280488336","https://openalex.org/W4315490546","https://openalex.org/W3203510009","https://openalex.org/W4324120940","https://openalex.org/W4293105510","https://openalex.org/W4319224981","https://openalex.org/W4321610845","https://openalex.org/W4280579438","https://openalex.org/W7134137019"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1],"glucagon-like":[2],"peptide-1":[3],"(GLP-1)":[4],"receptor":[5],"agonists":[6],"(RA)":[7],"have":[8],"increasingly":[9],"gained":[10],"prominence":[11],"in":[12,48,54,71,110,118,126,158,183],"the":[13,49,74,103,150,154,171,189],"treatment":[14,75],"of":[15,36,51,76,83,102,192],"type":[16],"2":[17,90,146],"diabetes":[18],"(T2D)":[19],"based":[20],"on":[21,142],"their":[22],"glycemic":[23],"benefits":[24],"and":[25,29,85,88,94,112,122,137,165,186],"favorable":[26],"body":[27,166],"weight":[28,167],"cardiorenal":[30],"effects.":[31],"Despite":[32],"this,":[33],"continued":[34],"development":[35,72],"therapeutics":[37],"with":[38,57,120,160],"superior":[39],"efficacy":[40,93],"is":[41,62],"important":[42],"to":[43,152,162,180],"help":[44],"address":[45],"persistent":[46],"challenges":[47],"attainment":[50],"metabolic":[52],"goals":[53],"many":[55],"patients":[56,119],"T2D.":[58,77],"AREAS":[59],"COVERED:":[60],"Tirzepatide":[61],"an":[63,100],"unimolecular":[64],"dual":[65],"glucose-dependent":[66],"insulinotropic":[67],"polypeptide":[68],"(GIP)/GLP-1":[69],"RA":[70],"for":[73],"This":[78],"review":[79,128],"summarizes":[80,114],"key":[81],"characteristics":[82],"tirzepatide":[84,148],"Phase":[86,89,105,145,173],"1":[87],"clinical":[91,107,133,175],"trial":[92,108,176],"safety":[95],"results.":[96],"Additionally,":[97],"it":[98],"provides":[99],"overview":[101],"ongoing":[104,172],"3":[106,174],"program":[109,177],"T2D":[111,159],"briefly":[113],"recently":[115],"initiated":[116],"studies":[117],"obesity":[121],"nonalcoholic":[123],"steatohepatitis.":[124],"Information":[125],"this":[127,193],"comes":[129],"primarily":[130],"from":[131,144,170],"published":[132],"trials,":[134,147],"manufacturer's":[135],"websites,":[136],"ClinicalTrials.gov.":[138],"EXPERT":[139],"OPINION:":[140],"Based":[141],"data":[143],"has":[149],"potential":[151],"be":[153],"most":[155],"efficacious":[156],"therapy":[157],"respect":[161],"both":[163],"glucose":[164],"control.":[168],"Data":[169],"should":[178],"start":[179],"become":[181],"available":[182],"late":[184],"2020":[185],"will":[187],"determine":[188],"future":[190],"course":[191],"promising":[194],"therapeutic":[195],"agent.":[196]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3090176981","counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":15},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-10-08T00:00:00"}
